The behavior of MET immunoreactivity across the remaining 179 cancer surfaces, was visualized by displaying corresponding percentages of MET positive – moderate (2) to strong (3) immunoreactivity (Materials and Methods) – cancer cells in the center and periphery as data points in a scatter plot (Supplementary Figure S5A). This evidence concerns the gene MET and cancer.